This invention relates to a class of quinoline quinones, which are useful for the therapy of immediate hypersensitivity reactions, such as asthma, and in treating any condition characterized by excessive release of leukotrienes. This invention also includes a method for treating these conditions, which comprises administering to animals, including humans, an effective dose of the quinoline quinone compounds. A further part of this invention is pharmaceutical formulations containing these pharmacologically-active compounds.
6-Substituted-quinoline-5,8-quinones useful for therapy of immediate hypersensitivity reactions and conditions characterized by excessive release of leukotriene.
6-取代-喹啉-5,8-醌,可用于治疗即时超敏反应和以白三烯释放过多为特征的病症。
Jacobs; Heidelberger, Journal of the American Chemical Society, 1922, vol. 44, p. 1083